Skip to content
10-K

Annual Report

Five Prime Therapeutics, Inc.

0001564590-21-014463

← back to feed
Filed
Mar 22, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Mar 15, 2021 46.57M sh
Capex FY 2020 · Dec 31, 2020 $56K
Capex FY 2020 · Dec 31, 2019 $1.78M
Capex FY 2020 · Dec 31, 2018 $11.33M
Operating Cash Flow FY 2020 · Dec 31, 2020 −$64.65M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$113.87M
Operating Cash Flow FY 2020 · Dec 31, 2018 −$122.51M
Cash And Equivalents FY 2020 · Dec 31, 2020 $69.42M
Cash And Equivalents FY 2020 · Dec 31, 2019 $55.8M
Cash And Equivalents FY 2020 · Dec 31, 2018 $43.95M
Cash And Equivalents FY 2020 · Dec 31, 2017 $59.79M
Stockholders Equity FY 2020 · Dec 31, 2020 $265.1M
Stockholders Equity FY 2020 · Dec 31, 2019 $150.47M
Stockholders Equity FY 2020 · Dec 31, 2018 $265.14M
Stockholders Equity FY 2020 · Dec 31, 2017 $265.2M
Current Liabilities FY 2020 · Dec 31, 2020 $22.18M
Current Liabilities FY 2020 · Dec 31, 2019 $23.02M
Current Assets FY 2020 · Dec 31, 2020 $292.41M
Current Assets FY 2020 · Dec 31, 2019 $166.72M
Total Assets FY 2020 · Dec 31, 2020 $331.65M
Total Assets FY 2020 · Dec 31, 2019 $224.14M
Sga Expense FY 2020 · Dec 31, 2020 $40.56M
Sga Expense FY 2020 · Dec 31, 2019 $42.75M
Sga Expense FY 2020 · Dec 31, 2018 $39.67M
Rd Expense FY 2020 · Dec 31, 2020 $65.49M
Rd Expense FY 2020 · Dec 31, 2019 $114.06M
Rd Expense FY 2020 · Dec 31, 2018 $156.35M
Net Income FY 2020 · Dec 31, 2020 −$20.85M
Net Income FY 2020 · Dec 31, 2020 −$84.33M
Net Income FY 2020 · Sep 30, 2020 −$26.42M
Net Income FY 2020 · Jun 30, 2020 −$16.94M
Net Income FY 2020 · Mar 31, 2020 −$20.12M
Net Income FY 2020 · Dec 31, 2019 −$31.36M
Net Income FY 2020 · Dec 31, 2019 −$137.2M
Net Income FY 2020 · Sep 30, 2019 −$36.07M
Net Income FY 2020 · Jun 30, 2019 −$34.39M
Net Income FY 2020 · Mar 31, 2019 −$35.39M
Net Income FY 2020 · Dec 31, 2018 −$140.45M
Operating Income FY 2020 · Dec 31, 2020 −$92.87M
Operating Income FY 2020 · Dec 31, 2019 −$141.94M
Operating Income FY 2020 · Dec 31, 2018 −$146.16M
Revenue FY 2020 · Dec 31, 2020 $13.18M
Revenue FY 2020 · Sep 30, 2020 $2.05M
Revenue FY 2020 · Jun 30, 2020 $3.42M
Revenue FY 2020 · Mar 31, 2020 $8.41M
Revenue FY 2020 · Dec 31, 2019 $3.21M
Revenue FY 2020 · Dec 31, 2019 $14.87M
Revenue FY 2020 · Sep 30, 2019 $2.98M
Revenue FY 2020 · Jun 30, 2019 $3.33M
Revenue FY 2020 · Mar 31, 2019 $5.35M
Revenue FY 2020 · Dec 31, 2018 $49.87M